SAFS (Safescience, Inc.) formerly IGGI. Hot Potential

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical SAFS (Safescience, Inc.) formerly IGGI. Hot Potential

Previous 10

To: Bob Trocchi who wrote (100)	9/3/1999 9:33:00 AM
From: Daniel Levin	of 110

Nothing in this article is new, something does seem strange with all these artcile coming out of nowhere about a company that hardly has a following. I have read both articles and I have used SAFS products myself and am quite happy with them. As far as the articles go they all seem to have an agenda and none of them give you any negative facts. If you want to short this stock go ahead but reread the last paragraph of the street.com article where it says that a positive news report could sky rocket this stock back to its high, I myself am always looking to add to my position at a good price so these short term drifts down do not affect me. In my opinion I am quite content on sitting on this stock for 5-10 years if I need to.

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Daniel Levin who wrote (101)	9/8/1999 1:47:00 AM
From: JMarcus	of 110

In case you hadn't noticed (small chance of that), the plunge in the stock price bottomed and rebounded on the press release that, contrary to rumor, insiders have not been dumping stock. There sure seemed to be a concerted effort to drive the stock price down, but it looks like that effort has now run its course. I got in at 14-5/8 today and intend to hold this position for a good long term. There are so many ways for this company to win--it is really quite amazing. Marc

Share	RecommendKeepReply Mark as Last Read

To: Andrew G. who wrote ()	9/10/1999 7:15:00 AM
From: gringodoc	of 110

Boston Globe slams SAFS: boston.com

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: gringodoc who wrote (103)	9/10/1999 10:00:00 AM
From: Daniel Levin	of 110

Reread the article. It does nothing of the sort.

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Daniel Levin who wrote (104)	9/10/1999 10:17:00 AM
From: DaveAu	of 110

You need to re-read it. Some pretty slimy characters associated with this scam: "Pierce is best known in downtown financial circles as the Lehman Brothers broker who executed stock and option transactions for former Centennial Technologies Inc. chief executive Emanuel Pinez, the man at the center of a huge 1997 stock fraud scandal." "Nahmias, the other SafeScience investor contact, also spent part of his career as a stockbroker. The National Association of Securities dealers barred him from association with any NASD firm in any capacity in 1996 as a result of a disciplinary case. Nahmias had been censured once before by the NASD and temporarily barred by state regulators in Tennessee for ''dishonest and unethical business practices'' in 1988."

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: DaveAu who wrote (105)	9/10/1999 10:29:00 AM
From: Daniel Levin	of 110

And what about the rest of the article??????

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Daniel Levin who wrote (106)	9/10/1999 10:39:00 AM
From: DaveAu	of 110

<<And what about the rest of the article?????? >> The rest is filled with old news such as the dispute about who owns the technology. Do you expect them to be profitable soon? If not, how long do you think their money is going to last? Do you think they can sell equity at or above the current price ? BJ

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: DaveAu who wrote (107)	2/14/2000 5:57:00 PM
From: Oak Tree	of 110

I was just asked to take part in a safescience study for GBC590, for patients with pancreatic ca. This company has not done its homework. My opinion is, as a physicians and scientists that this is a clear short stock.

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Oak Tree who wrote (108)	2/14/2000 7:45:00 PM
From: DaveAu	of 110

I agree it's a good short but you may have trouble getting a borrow. I was forced to buy in half my position so I closed it all out because it was getting too small to worry about. That's why I stopped following it. Dave

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: DaveAu who wrote (109)	5/3/2000 12:07:00 PM
From: Silicon Trader	of 110

Wednesday May 3, 11:35 am Eastern Time Company Press Release SOURCE: SafeScience, Inc. SafeScience, Inc. Receives IRB Approval For Phase II Studies of GBC-590 For Treatment of Pancreatic Cancer at University of Rochester Cancer Center

Share	RecommendKeepReply Mark as Last Read